Humanoid Robotics Funding: Europe Gets a $1.35B Robot Unicorn

A new European contender

The humanoid robotics race has a new headline from outside Silicon Valley. Humanoid, a British company, has raised $152 million at a $1.35 billion valuation, and its own announcement calls it Europe's newest robot unicorn 2. A follow-up press item, dated a few days later, frames the company as pointing the way forward for European tech 2. The funding post is dated July 21 and the press mention July 26, both in what the company's site lists as 2026 2.

The company's site lists dated updates going back to January 2. That suggests a steady flow of news through the year, ending in a funding round large enough to put Humanoid among the industry's well-capitalized players. The available material does not say who led the round, how the money will be spent, or what products Humanoid is shipping. Those details matter for judging the valuation, and they are not yet public in what has been reported here.

The American backdrop: Figure and OpenAI

Humanoid's raise lands in a field already shaped by bold claims from US companies. In April 2025, the robotics blog RoboZaps reported that Figure's humanoid robot, powered by the company's Helix AI system, was set to enter homes in 2025. That would be two years ahead of schedule 1. The same outlet also asked whether OpenAI's move into humanoid robots is a bold masterstroke or Silicon Valley overreach 1.

The two items show the two forces behind the sector. One is the promise that advances in AI models, such as Figure's Helix, can turn general-purpose robots from lab demos into consumer products faster than expected. The other is doubt about whether that promise holds up. Calling OpenAI's effort possible "overreach" reflects a real question: can expertise in AI software carry over to the much harder problems of hardware, manufacturing and physical safety 1?

Where the stories meet and where they differ

The two sets of coverage overlap on one point. Investors and companies are betting that humanoid robots are close to commercial viability. Figure's accelerated home timeline 1 and Humanoid's unicorn valuation 2 both express that confidence. Each assumes that progress in AI will unlock the market soon enough to justify heavy spending now.

They differ in where the story takes place and how it is told. The RoboZaps coverage centers on American firms and treats their ambitions with some skepticism, as the "masterstroke or overreach" framing shows 1. Humanoid's communications are promotional and come from the company itself. They focus on the funding milestone and on Europe's place in the industry 2. Readers should keep in mind that a company announcing its own valuation is not independent analysis.

Timing also deserves caution. Figure's ahead-of-schedule claim was published on April 1, 2025 1. Whatever the intent, aggressive launch dates in robotics have often slipped. Whether a Figure robot actually reached ordinary homes in 2025 is not shown in this coverage, so the claim should be read as a stated ambition, not a confirmed result.

Why it matters

The Humanoid round matters most as a sign of geography. Robotics and frontier AI funding has long been concentrated in the United States and China. A British company reaching a $1.35 billion valuation in humanoids 2 suggests European investors are willing to back hardware-heavy AI bets at scale. The company itself presents this as a model for European tech 2. That is a reasonable reading of the symbolism, though one deal does not make a trend.

For the wider market, the picture is a sector priced on expectations. Figure's home-robot timeline 1, OpenAI's reported interest in humanoids 1 and Humanoid's valuation 2 all point to capital and attention moving toward embodied AI. What is still missing is evidence of large-scale deployment: robots doing paid work reliably, in real homes or workplaces, at costs buyers will accept.

The reading

The most defensible conclusion is that humanoid robotics has moved from a niche research pursuit to a competitive, well-funded category with players on both sides of the Atlantic. Humanoid's raise is real money and a meaningful marker for Europe 2. The more aggressive product claims elsewhere, such as early home rollouts, still deserve the skepticism that commentators have applied to newcomers like OpenAI 1. Valuations show what investors believe. Shipped robots will show whether those beliefs were right.